DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 02 · Volume 77 · 1997 DOI: 10.1055/s-008-40689

Obituary

226
Jamieson, G A: Pia Glas-Greenwalt, M. D., 1932-1996

Review Article

227
Rowley, Andrew F; Hill, Darryl J; Ray, Clare E; Munro, Roger: Haemostasis in Fish – An Evolutionary Perspective

Original Article

234
Hay, C R M; Oilier, W; Pepper, L; Cumming, A; Keeney, S; Goodeve, A C; Colvin, B T; Hill, F G H; Preston, F E; Peake, I R; UKHCDO Inhibitor Working Party: HLA Class II Profile: A Weak Determinant of Factor VIII Inhibitor Development in Severe Haemophilia A
238
Oldenburg, J; Picard, J K; Schwaab, R; Brackmann, H H; Tuddenham, E G D; Simpson, E: HLA Genotype of Patients with Severe Haemophilia A due to Intron 22 Inversion with and without Inhibitors of Factor VIII
243
Yamaguchi, Hiroshi; Azuma, Hiroyuki; Shigekiyo, Toshio; Inoue, Hideo; Saito, Shiro: A Novel Missense Mutation in the Endoglin Gene in Hereditary Hemorrhagic Telangiectasia
248
Norlund, Lena; Holm, Johan; Zöller, Bengt; Öhlin, Ann-Kristin: A Common Thrombomodulin Amino Acid Dimorphism Is Associated with Myocardial Infarction
252
Guasch, Joan F; Lensen, Ruud P M; Bertina, Rogier M: Molecular Characterization of a Type I Quantitative Factor V Deficiency in a Thrombosis Patient that Is “Pseudo Homozygous” for Activated Protein C Resistance
258
Seixas, C A; Hessel, G; Ribeiro, C C; Arruda, V R; Annichino-Bizzacchi, J M: Factor V Leiden Is Not Common in Children with Portal Vein Thrombosis
262
Janssen, M C H; Heebels, A E; de Metz, M; Verbruggen, H; Wollersheim, H; Janssen, S; Schuurmans, M M J; Nováková, I R O: Reliability of Five Rapid D-Dimer Assays Compared to ELISA in the Exclusion of Deep Venous Thrombosis
267
Cofrancesco, E; Cortellaro, M; Corradi, A; Ravasi, F; Bertocchi, F: Coagulation Activation Markers in the Prediction of Venous Thrombosis after Elective Hip Surgery
270
Chan, Anthony K C; Leaker, Michael; Burrows, Frederick A; Williams, William G; Gruenwald, Colleen E; Whyte, Linda; Adams, Margaret; Brooker, Lu Ann; Adams, Helen; Mitchell, Lesley; Andrew, Maureen: Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass
278
Gando, Satoshi; Kameue, Takashi; Nanzaki, Satoshi; Nakanishi, Yoshimi: Massive Fibrin Formation with Consecutive Impairment of Fibrinolysis in Patients with Out-of-Hospital Cardiac Arrest
283
Phillips, W S; Smith, J; Greaves, M; Preston, F E; Channer, K S: An Evaluation and Improvement Program for Inpatient Anticoagulant Control
289
Lee, S H; Looareesuwan, S; Chan, J; Wilairatana, P; Vanijanonta, S; Chong, S M; Chong, B H: Plasma Macrophage Colony-Stimulating Factor and P-Selectin Levels in Malaria-Associated Thrombocytopenia
294
Tomo, Kenjiro; Takayama, Hiroshi; Kaneko, Yoshiyuki; Fujita, Jun; Nakamura, Michihiro; Ueda, Natsuo; Yamamoto, Shozo; Okuma, Minoru: Qualitative Platelet 12-Lipoxygenase Abnormality in a Patient with Essential Thrombocythemia
298
Fijnvandraat, K; Berntorp, E; ten Cate, J W; Johnsson, H; Peters, M; Savidge, G; Tengborn, L; Spira, J; Stahl, C: Recombinant, B-domain Deleted Factor VIII (r-VIII SQ): Pharmacokinetics and Initial Safety Aspects in Hemophilia A Patients
303
Pajkrt, Dasja; Lerch, Peter G; van der Poll, Tom; Levi, Marcel; Illi, Marlies; Doran, Jan E; Arnet, Beat; van den Ende, Abraham; ten Cate, Jan Wouter; van Deventer, Sander J H: Differential Effects of Reconstituted High-density Lipoprotein on Coagulation, Fibrinolysis and Platelet Activation during Human Endotoxemia
308
Kruithof, Egbert K O; Agay, Diane; Mestries, Jean Claude; Gascon, Marie-Paule; Ythier, Arnaud: The Effect of Factor Xa/Phospholipid Infusion on the Acute Phase Response in Baboons
312
Peyrou, V; Béguin, S; Boneu, B; Hemker, H C: The Activity of Unfractionated Heparin and Low Molecular Weight Heparins in Rabbit Plasma – The Need for Using Absolute Anti-factor Xa and Antithrombin Activities
317
Brieger, David; Dawes, Joan: Production Method Affects the Pharmacokinetic and Ex Vivo Biological Properties of Low Molecular Weight Heparins
323
Chang, Wun-Shaing W; Harper, Paul L: Commercial Antithrombin Concentrate Contains Inactive L-forms of Antithrombin
329
Pepe, Guglielmina; Rickards, Olga; Vanegas, Olga Camacho; Brunelli, Tamara; Gori, Anna Maria; Giusti, Betti; Attanasio, Monica; Prisco, Domenico; Gensini, Gian Franco; Abbate, Rosanna: Prevalence of Factor V Leiden Mutation in Non-European Populations
332
Svensson, Peter J; Zöller, Bengt; Dahlbäck, Björn: Evaluation of Original and Modified APC-Resistance Tests in Unselected Outpatients with Clinically Suspected Thrombosis and in Healthy Controls
336
Goudemand, J; Caron, C; De Prost, D; Derlon, A; Borg, J Y; Sampol, J; Sié, P; for the Working Group on Hemostasis of the Société Française de Biologie Clinique and for the Groupe d’Etudes sur I’Hémostase et la Thrombose: Evaluation of Sensitivity and Specificity of a Standardized Procedure Using Different Reagents for the Detection of Lupus Anticoagulants
343
Chouhan, Vibhuti D; De La Cadena, Raul A; Nagaswami, Chandrasekaran; Weisel, John W; Kajani, Mehdi; Rao, A Koneti: Simultaneous Occurrence of Human Antibodies Directed against Fibrinogen, Thrombin, and Factor V Following Exposure to Bovine Thrombin: Effects on Blood Coagulation, Protein C Activation and Platelet Function
350
Bijnens, A P; Knockaert, I; Cousin, E; Kruithof, E K O; Declerck, P J: Expression and Characterization of Recombinant Porcine Plasminogen Activator Inhibitor-1
357
Mansfield, Michael W; Stickland, Max H; Grant, Peter J: PAI-1 Concentrations in First-degree Relatives of Patients with Non-insulin-dependent Diabetes: Metabolic and Genetic Associations
362
Lijnen, H R; Wagner, E F; Collen, D: Plasminogen-dependent and -independent Proteolytic Activity of Murine Endothelioma Cells with Targeted Inactivation of Fibrinolytic Genes
368
Nagata, Koh-ichi; Okano, Yukio; Nozawa, Yoshinori: Differential Expression of Low Mr GTP-binding Proteins in Human Megakaryoblastic Leukemia Cell Line, MEG-01, and their Possible Involvement in the Differentiation Process
376
Lages, Bruce; Weiss, Harvey J: Enhanced Increases in Cytosolic Ca2+ in ADP-Stimulated Platelets from Patients with Delta-Storage Pool Deficiency – A Possible Indicator of Interactions between Granule-Bound ADP and the Membrane ADP Receptor
383
Bellucci, S; Girma, J P; Lozano, M; Meyer, D; Caen, J P: Impaired Prothrombin Consumption in Bernard-Soulier Syndrome Is Corrected In Vitro by Human Factor VIII
387
Vischer, Ulrich M; Ingerslev, Jørgen; Wollheim, Claes B; Mestries, Jean-Claude; Tsakiris, Dimitrios A; Haefeli, Walter E; Kruithof, Egbert K O: Acute von Willebrand Factor Secretion from the Endothelium In Vivo: Assessment through Plasma Propeptide (vWf:AgII) Levels
394
Ikeda, Kei; Nagasawa, Kohei; Horiuchi, Takahiko; Tsuru, Tomomi; Nishizaka, Hiroaki; Niho, Yoshiyuki: C5a Induces Tissue Factor Activity on Endothelial Cells
399
Nagase, Hideki; Kitazato, Keiko T; Sasaki, Eiji; Hattori, Masahiko; Kitazato, Kenji; Saito, Hidehiko: Antithrombin III-Independent Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on Acute Thromboembolism in Mice

Letter to the Editor

403
Ozawa, Tetsuo; Takikawa, Yasuhiro; Niiya, Kenji; Fujiwara, Takao; Suzuki, Kazuyuki; Sato, Shunichi; Sakuragawa, Nobuo: Antithrombin Morioka (Cys 95-Arg): A Novel Missense Mutation Causing Type I Antithrombin Deficiency
404
Demiroğlu, Halûk; Banşta, Ibrahim; Dündar, Semra: The Effects of Age and Menopause on Erythrocyte Aggregation
405
Rintelen, Claudia; Pabinger, Ingrid; Lechner, Klaus; Mann-halter, Christine: Impact of Factor V Leiden Mutation on Duration of Anticoagulation after a Single Thromboembolic Event
405
MacGregor, I; Drummond, O; Prowse, C: In Vivo Modelling of Coagulation Factor Concentrate Thrombogenicity
406
Smith, M P; Rice, K M; Savidge, G F: Successful Clinical Use of a Plasma-derived, Dual Virus Inactivated Factor VIII Concentrate Incorporating Solvent-detergent and Dry Heat Treatment